Osteopathic Manipulative Therapy Effects on Prolonged Post-COVID Olfactory Dysfunction
1 other identifier
interventional
20
1 country
1
Brief Summary
The goal of this project is to determine the efficacy of a treatment method that increase a participants sense of smell after suffering from COVID-19 related decline in smell. Participants have to be greater than 14 days from positive COVID-19 test and still have a decreased sense of smell. https://jaoa.org/article.aspx?articleid=2765119 this article is a review of literature regarding why OMT can have a positive effect on individuals suffering from COVID-19 Anosmia: Complete loss of smell Hyposmia: Decrease in smell
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 31, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 13, 2021
CompletedFirst Submitted
Initial submission to the registry
November 5, 2021
CompletedFirst Posted
Study publicly available on registry
November 9, 2021
CompletedNovember 9, 2021
March 1, 2021
6 months
November 5, 2021
November 5, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Smell Intensity
Participants will smell the 4 substances blindfolded and will rank each one from 0-10, 0 being no smell and 10 be pre-COVID smell. Participant will then be treated either with OMT or placebo and then asked to resmell the same 4 smell substances and rank them on the same scale.
10 minutes will elapse between treatment and post-treatment smell testing.
Smell Identification
Participants will smell the 4 substances blindfolded and attempt to identify the smells. Participants will then receive treatment either OMT or Placebo and will smell the same 4 substances while attempting to identify them again. Correct answers were given a score of "1" and incorrect answers were given a smell of "0"
10 minutes will elapse between treatment and post-treatment smell testing.
Other Outcomes (1)
Quantitative smell experience
10 minutes will elapse between treatment and post-treatment smell testing.
Study Arms (2)
OMT Group
EXPERIMENTALThe OMT protocol treatment sequence was performed in the following order: 1\. Rib raising from a seated position 2. Suboccipital Release from a supine position 3. Thoracic Inlet Release 4. Miller Lymphatic Pump 5. Pedal Pump 6. Suboccipital Release 7. Cranial Sinus Effleurage 1. Engaging the sagittal midline of occiput with pressure until release of the tissue is palpated 2. Direct pressure along the external region of the transverse sinus until release of the tissue is palpated. 3. Pressure on sagittal suture with transverse traction until release of the tissue is palpated 4. Pressure on metopic suture with transverse traction in a pulsatile manner 5. Vault hold 1\. Appreciate cranial respiratory motion 2. Diagnose cranial strain pattern 3. Place cranial strain pattern into position of ease
Placebo/Light Touch/Sham Group
PLACEBO COMPARATORParticipants in the sham/placebo group were lightly touched in equivalent positions to the OMT treatments. First, sham participants were lightly touched on the thoracic cage while seated, followed by light touch of the neck, chest, feet, and cranium while supine. The length of light touch was modeled after the approximate time needed for the OMT matching each treatment region. Each treatment sequence lasted about 20 minutes in total.
Interventions
Osteopathic Manipulative Therapy is a type of hands-on manipulative medicine where the physician uses their hands and knowledge of anatomy to encourage the human body to reattain homeostasis.
Eligibility Criteria
You may qualify if:
- years or older
- Positive COVID test greater than 14 days prior
- Self-identify a decrease in smell after the resolution of their infection
You may not qualify if:
- Complete smell recovery after resolution of infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ohio Universitylead
- American Osteopathic Foundationcollaborator
Study Sites (1)
Ohio University Heritage College of Medicine - Dublin
Dublin, Ohio, 43016, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Steven Walkowski, DO
Ohio University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Individual testing smell function was masked to whether participant was in treatment group or placebo
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2021
First Posted
November 9, 2021
Study Start
March 31, 2021
Primary Completion
September 13, 2021
Study Completion
September 13, 2021
Last Updated
November 9, 2021
Record last verified: 2021-03